Systemic inflammation and circadian rhythm of cardiac autonomic modulation

Autonomic Neuroscience: Basic and Clinical

Volumn 162, Issue 1-2, 2011, Pages 72-76

  Li, Xian ^a,b   Shaffer, Michele L ^a   Rodríguez Colón, Sol M ^a   He, Fan ^a   Bixler, Edward O ^a   Vgontzas, Alexandros N ^a   Wolbrette, Deborah L ^a   Wu, Chuntao ^a   Ball, Richard W ^c   Liao, Duanping ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b FUWAI HOSPITAL   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

C reactive protein; Community population; Heart rate variability; Inflammatory marker; Meta analysis; Periodic regression; Random effects model

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIAC AUTONOMIC MODULATION; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; COMMUNITY SAMPLE; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE POTENTIAL; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; OSCILLATION; PRIORITY JOURNAL; SYSTEMIC INFLAMMATION;

AGED; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART; HEART RATE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PARTICULATE MATTER; REGRESSION ANALYSIS;

EID: 79958013280     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2011.03.002     Document Type: Article

References (35)

1. Araujo F., Antelmi I., Pereira A.C., Latorre Mdo.R., Grupi C.J., Krieger J.E., Mansur A.J. Lower heart rate variability is associated with higher serum high-sensitivity c-reactive protein concentration in healthy individuals aged 46years or more. Int. J. Cardiol. 2006, 107:333-337.
2. Banks W.A., Kastin A.J. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 1991, 48:117-121.
3. Biggerm J.T.J., Fleiss J.L., Steinman R.C., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992, 85:164-171.
4. Blake G.J., Rifai N., Buring J.E., Ridker P.M. Blood pressure, c-reactive protein, and risk of future cardiovascular events. Circulation 2003, 108:2993-2999.
5. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
6. Dekker J.M., Crow R.S., Folsom A.R., Hannan P.J., Liao D., Swenne C.A., Schouten E.G. Low heart rate variability in a 2-min rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC study. Atherosclerosis risk in communities. Circulation 2000, 102:1239-1244.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
8. D'Negri C.E., Marelich L., Vigo D., Acunzo R.S., Girotti L.A., Cardinali D.P., Siri L.N. Circadian periodicity of heart rate variability in hospitalized angor patients. Clin. Auton. Res. 2005, 15:223-232.
9. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
10. He F., Shaffer M., Li X., Rodriguez-Colon S., Wolbrette D., Williams R., Cascio W., Liao D. Individual-level pm (2.5) exposure and the time course of impaired heart rate variability: the APACR study. J. Expo. Sci. Environ. Epidemiol. 2011, 21:65-73.
11. Jensen-Urstad M., Jensen-Urstad K., Ericson M., Johansson J. Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J. Intern. Med. 1998, 243:33-40.
12. Kucharska-Newton A.M., Couper D.J., Pankow J.S., Prineas R.J., Rea T.D., Sotoodehnia N., Chakravarti A., Folsom A.R., Siscovick D.S., Rosamond W.D. Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the Atherosclerosis Risk in Communities (aric) cohort. Arterioscler. Thromb. Vasc. Biol. 2009, 29:2182-2190.
13. La Rovere M.T., Pinna G.D., Maestri R., Mortara A., Capomolla S., Febo O., Ferrari R., Franchini M., Gnemmi M., Opasich C., Riccardi P.G., Traversi E., Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003, 107:565-570.
14. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics 1982, 38:963-974.
15. Lanza G.A., Sgueglia G.A., Cianflone D., Rebuzzi A.G., Angeloni G., Sestito A., Infusino F., Crea F., Maseri A. Relation of heart rate variability to serum levels of c-reactive protein in patients with unstable angina pectoris. Am. J. Cardiol. 2006, 97:1702-1706.
16. Liao D., Cai J., Rosamond W.D., Barnes R.W., Hutchinson R.G., Whitsel E.A., Rautaharju P., Heiss G. Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC study. Atherosclerosis Risk in Communities study. Am. J. Epidemiol. 1997, 145:696-706.
17. Liao D., Shaffer M.L., Rodriguez-Colon S., He F., Li X., Wolbrette D.L., Yanosky J., Cascio W.E. Acute adverse effects of fine particulate air pollution on ventricular repolarization. Environ. Health Perspect. 2010, 118:1010-1015.
18. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
19. Lombardi F., Sandrone G., Mortara A., La Rovere M.T., Colombo E., Guzzetti S., Malliani A. Circadian variation of spectral indices of heart rate variability after myocardial infarction. Am. Heart J. 1992, 123:1521-1529.
20. Madsen T., Christensen J.H., Toft E., Schmidt E.B. C-reactive protein is associated with heart rate variability. Ann. Noninvasive Electrocardiol. 2007, 12:216-222.
21. Malpas S.C., Purdie G.L. Circadian variation of heart rate variability. Cardiovasc. Res. 1990, 24:210-213.
22. Massin M.M., Maeyns K., Withofs N., Ravet F., Gerard P. Circadian rhythm of heart rate and heart rate variability. Arch. Dis. Child. 2000, 83:179-182.
23. Meier-Ewert H.K., Ridker P.M., Rifai N., Price N., Dinges D.F., Mullington J.M. Absence of diurnal variation of c-reactive protein concentrations in healthy human subjects. Clin. Chem. 2001, 47:426-430.
24. Nakagawa M., Iwao T., Ishida S., Yonemochi H., Fujino T., Saikawa T., Ito M. Circadian rhythm of the signal averaged electrocardiogram and its relation to heart rate variability in healthy subjects. Heart 1998, 79:493-496.
25. Nelson J.J., Liao D., Sharrett A.R., Folsom A.R., Chambless L.E., Shahar E., Szklo M., Eckfeldt J., Heiss G. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (aric) study. Am. J. Epidemiol. 2000, 151:468-477.
26. Niemela M.J., Airaksinen K.E., Huikuri H.V. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J. Am. Coll. Cardiol. 1994, 23:1370-1377.
27. Phillips A.N., Neaton J.D., Cook D.G., Grimm R.H., Shaper A.G. Leukocyte count and risk of major coronary heart disease events. Am. J. Epidemiol. 1992, 136:59-70.
28. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997, 336:973-979.
29. Saeed R.W., Varma S., Peng-Nemeroff T., Sherry B., Balakhaneh D., Huston J., Tracey K.J., Al-Abed Y., Metz C.N. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 2005, 201:1113-1123.
30. Sajadieh A., Nielsen O.W., Rasmussen V., Hein H.O., Abedini S., Hansen J.F. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur. Heart J. 2004, 25:363-370.
31. Sloan R.P., McCreath H., Tracey K.J., Sidney S., Liu K., Seeman T. Rr interval variability is inversely related to inflammatory markers: the cardia study. Mol. Med. 2007, 13:178-184.
32. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
33. Thayer J.F., Fischer J.E. Heart rate variability, overnight urinary norepinephrine and c-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J. Intern. Med. 2009, 265:439-447.
34. Tsuji H., Larson M.G., Venditti F.J.J., Manders E.S., Evans J.C., Feldman C.L., Levy D. Impact of reduced heart rate variability on risk for cardiac events. the Framingham Heart Study. Circulation 1996, 94:2850-2855.
35. Yue W., Schneider A., Ruckerl R., Koenig W., Marder V., Wang S., Wichmann H., Peters A., Zareba W. Relationship between electrocardiographic and biochemical variables in coronary artery disease. Int. J. Cardiol. 2007, 119:185-191.